Indonesia vs Mozambique: Reported cases of paralytic polio from vaccine-derived viruses
Indonesia
6 cases
in 2023
Mozambique
5 cases
in 2023
Indonesia rank
11th
Mozambique rank
13th
Reported cases of paralytic polio from vaccine-derived viruses over time
- Indonesia
- Mozambique
How they compare
Indonesia currently reports 6 cases against 5 cases in Mozambique, a difference of 1 cases.
That makes Indonesia's figure about 1.2 times Mozambique's.
The two have swapped places 3 times across 23 shared years of data; in 2001 it was Mozambique ahead.
Indonesia ranks 11th and Mozambique ranks 13th of 173 countries.
Across the 3 decades both report, Indonesia averaged higher in 1 and Mozambique in 2.
Head to head by decade
| Decade | Indonesia | Mozambique | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.11 cases | 0 cases | 5.11 cases | Indonesia |
| 2010s | 0.1 cases | 0.3 cases | 0.2 cases | Mozambique |
| 2020s | 1.75 cases | 8.25 cases | 6.5 cases | Mozambique |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher reported cases of paralytic polio from vaccine-derived viruses, Indonesia or Mozambique?
- Indonesia, at 6 cases against 5 cases in Mozambique as of 2023.
- What is the difference in reported cases of paralytic polio from vaccine-derived viruses between Indonesia and Mozambique?
- 1 cases, with Indonesia ahead.
- How many years of comparable data are there for Indonesia and Mozambique?
- 23 years are reported by both, from 2001 to 2023.
- How do Indonesia and Mozambique rank globally for reported cases of paralytic polio from vaccine-derived viruses?
- Indonesia ranks 11th and Mozambique ranks 13th of 173 countries.
- Where does this data come from?
- World Health Organization (2024) – processed by Our World in Data, published as Reported cases of paralytic polio from vaccine-derived viruses. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of cases of circulating vaccine-derived poliovirus detected in a given year.